Nano Retina
Artificial Retina
Health Tech & Life Sciences
Non Active, Aug 2023 ceased to operate
Company Overview
Snapshot
Founded in January 2009, Nano Retina operated with 11–50 employees. The company raised $750,000 across one funding round. In August 2023, Nano Retina ceased operations.
Business overview
Nano Retina developed a solution aimed at restoring sight for individuals with retinal degenerative diseases. Its core product, the NR600 Implant, is a miniature device designed to replace damaged photoreceptor cell functionality and stimulate healthy retinal cells. The implant, along with a pair of eyeglasses, provides full vision functionality through a minimally invasive surgical procedure. The company operated within the Health Tech & Life Sciences sector, focusing on medical devices and treatments for visually impaired patients.
Log in to access full profile ›Company Intelligence Q&A
- What is Nano Retina's primary product?
- Nano Retina developed the NR600 Implant, a miniature device intended to restore sight by replacing the functionality of damaged photoreceptor cells and stimulating healthy retinal cells.
- When was Nano Retina founded?
- Nano Retina was founded in January 2009.
- What is the status of Nano Retina?
- Nano Retina is currently non-active, having ceased operations in August 2023.
- How much capital did Nano Retina raise?
- Nano Retina raised a total of $750,000 across one funding round. This capital was secured in January 2010 through a grant from the BIRD Foundation.